Frontlight ResearchEarly access
Trial site
Grupo Medico Camino Sc
- 8running trials
- 5closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Chronic kidney disease2 trials
- Epilepsy2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Diabetic neuropathy1 trial
- Endometrial cancer1 trial
- Multiple sclerosis1 trial
- Obesity1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 39 trials
- Phase 24 trials
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company9 trials
- Xenon Pharmaceuticals Inc.2 trials
- Eisai Inc.1 trial
- Immunic AG1 trial
Running trials
Recruiting
Recruiting
Enrolling by invitation
Recruiting
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Epilepsy1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 14 Nov 2026